Atara Biotherapeutics, Inc.

Healthcare

NASDAQ:ATRA · NASDAQ Global Select

Market Cap $88.52M Beta 0.11 P/E (TTM) -14.7

$10.07 +1.96%

+$0.19 today

52W Low $3.92High $19.15

Vol 0.11M · Avg 1.40M

EPS (TTM) -$0.67Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+27.79%

Period High

$18.09

Period Low

$4.18

Latest

$10.07

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Ovid Therapeutics Inc.

NASDAQ:OVID

$311.91M

Sutro Biopharma, Inc.

NASDAQ:STRO

$285.64M

MacroGenics, Inc.

NASDAQ:MGNX

$258.81M

Shattuck Labs, Inc.

NASDAQ:STTK

$233.53M

Oramed Pharmaceuticals Inc.

NASDAQ:ORMP

$155.72M

InflaRx N.V.

NASDAQ:IFRX

$130.09M

Champions Oncology, Inc.

NASDAQ:CSBR

$89.71M

Coya Therapeutics, Inc.

NASDAQ:COYA

$89.04M

Clene Inc.

NASDAQ:CLNN

$60.40M

Context Therapeutics Inc.

NASDAQ:CNTX

$56.66M

What is the latest ATRA filing?

The latest filing shown is 3 dated Jun 15, 2026.

How many recent filings does ATRA have?

Intrinsic Alpha currently shows 20 recent filings for ATRA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.